Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1LK2

1.35A crystal structure of H-2Kb complexed with the GNYSFYAL peptide

1LK2 の概要
エントリーDOI10.2210/pdb1lk2/pdb
関連するPDBエントリー2vaa
分子名称H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B ALPHA CHAIN, Beta-2-microglobulin, INSULIN RECEPTOR, BETA-SUBUNIT, ... (9 entities in total)
機能のキーワードclass i mhc-peptide complex, high resolution, anisotropic and tls refinement, immune system
由来する生物種Mus musculus (house mouse)
詳細
タンパク質・核酸の鎖数3
化学式量合計45324.74
構造登録者
Luz, J.G.,Rudolph, M.G.,Wilson, I.A.,Eisen, H. (登録日: 2002-04-23, 公開日: 2003-11-11, 最終更新日: 2024-11-13)
主引用文献Rudolph, M.G.,Shen, L.Q.,Lamontagne, S.A.,Luz, J.G.,Delaney, J.R.,Ge, Q.,Cho, B.K.,Palliser, D.,McKinley, C.A.,Chen, J.,Wilson, I.A.,Eisen, H.N.
A peptide that antagonizes TCR-mediated reactions with both syngeneic and allogeneic agonists: functional and structural aspects.
J.Immunol., 172:2994-3002, 2004
Cited by
PubMed Abstract: We identify and consider some characteristics of a peptide antagonist for the Ag-specific receptor on 2C cells (the 2C TCR). The peptide, GNYSFYAL (called GNY), binds to H-2K(b), and a very high-resolution crystal structure of the GNY-K(b) complex at 1.35 A is described. Although the GNY peptide does not bind to L(d), the potency of GNY-K(b) as an antagonist is evident from its ability to specifically inhibit 2C TCR-mediated reactions to an allogenic agonist complex (QLSPFPFDL-L(d)), as well as to a syngeneic agonist complex (SIYRYYGL-K(b)). The crystal structure and the activities of alanine-substituted peptide variants point to the properties of the peptide P4 side chain and the conformation of the Tyr-P6 side chain as the structural determinants of GNYSFYAL antagonist activity.
PubMed: 14978103
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.35 Å)
構造検証レポート
Validation report summary of 1lk2
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon